HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melanie A Paquette Selected Research

1-hydroxy-3-amino-2-pyrrolidone

1/2008Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Melanie A Paquette Research Topics

Disease

5Dyskinesias (Dyskinesia)
06/2013 - 01/2008
5Parkinson Disease (Parkinson's Disease)
06/2013 - 01/2008
1Parkinsonian Disorders (Parkinsonism)
06/2010
1Schizophrenia (Dementia Praecox)
07/2009

Drug/Important Bio-Agent (IBA)

5Levodopa (L Dopa)FDA LinkGeneric
06/2013 - 01/2008
4Oxidopamine (6 Hydroxydopamine)IBA
11/2012 - 01/2008
3alpha- (4- fluorophenyl)- 4- (5- fluoro- 2- pyrimidinyl)- 1- piperazine butanolIBA
06/2013 - 01/2008
3N-Methylaspartate (NMDA)IBA
11/2012 - 01/2008
3Amantadine (Aman)FDA LinkGeneric
11/2012 - 01/2008
3Dextromethorphan (Racemethorphan)FDA LinkGeneric
11/2012 - 01/2008
2Dizocilpine Maleate (Dizocilpine)IBA
06/2010 - 01/2008
1Dopamine Agonists (Dopamine Agonist)IBA
06/2013
1Dihydrotachysterol (AT 10)IBA
06/2013
15-HT1A Serotonin ReceptorIBA
06/2013
11-hydroxy-3-amino-2-pyrrolidoneIBA
01/2008
1LigandsIBA
01/2008